Lisa Guerrettaz

Title: Lisa Guerrettaz: Innovator in Immune Regulatory Cell Research

Introduction

Lisa Guerrettaz is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of immunology, particularly in the development of methods for inducing myeloid suppressive cells. Her work aims to enhance therapeutic potential in treating various medical conditions.

Latest Patents

Lisa Guerrettaz holds a patent titled "Composition and methods for inducing myeloid suppressive cells and use thereof." This patent focuses on compositions and methods for manufacturing induced immune regulatory cells, including myeloid-derived suppressor cells (MDSCs), dendritic cells, and macrophages. The patent also outlines methods for modifying and modulating these cells to improve their effectiveness in treating autoimmune disorders, hematological malignancies, solid tumors, viral infections, neurodegenerative disorders, inflammatory conditions, and graft-versus-host disease (GvHD).

Career Highlights

Lisa is currently associated with Fate Therapeutics, Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the advancement of immune therapies.

Collaborations

Some of her notable coworkers include Philippe A Parone and Robert S Tacke, who collaborate with her on various research initiatives.

Conclusion

Lisa Guerrettaz is a trailblazer in the field of immune regulatory cell research, with a focus on developing innovative therapies for complex medical conditions. Her contributions are paving the way for future advancements in immunology.